The Board of Optometry met on July 18, 2019 in Orlando regarding adding Rocklatan to the formulary; the board dismissed the request as name-brands cannot be added, and the combined ingredients are already on the formulary.
Brand Names not allowed on formulary.
Posted in Latest News on July 23, 2019.
